Atlas Trials

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Clinical trial NCT03095781 · COMPLETED

Trial details

NCT number
NCT03095781
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal CarcinomaRecurrent Pancreatic CarcinomaStage III Colorectal CancerStage III Pancreatic CancerStage IIIA Colorectal CancerStage IIIB Colorectal CancerStage IV Colorectal CancerStage IV Pancreatic CancerStage IVA Colorectal CancerStage IVA Pancreatic Cancer
Start date
2017-07-07
Primary completion
2021-06-10
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.